Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02831816 · ClinicalTrials.gov registry record · Phase 3
Clinical Evaluation of Patient Preoperative Prep
A Phase 3 study of Surgical Skin Preparation, sponsored by Zurex Pharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 640
- Enrollment target
- 1
- Study location
NCT02831816 is a Phase 3 study of Surgical Skin Preparation that has completed, run by Zurex Pharma. The registered enrollment target is 640 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02831816, a Phase 3 study of Surgical Skin Preparation, has completed, sponsored by Zurex Pharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 640 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the study is to demonstrate the antimicrobial efficacy of the ZP Preoperative Prep on skin flora of the abdomen and inguinal regions of human subjects.
Conditions Studied
Interventions
- DRUG ZuraPrep
- DRUG ChloraPrep
- DRUG ZP Vehicle
Study Locations (1)
Montana
- BioScience Laboratories, Inc. - Bozeman
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 640 participants |
| Start Date | 2016-08-03 |
| Est. Completion | 2017-08-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02831816
The ClinicalTrials.gov registry entry for NCT02831816 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 640 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zurex Pharma, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Surgical Skin Preparation appearing as the primary indexed condition, and to 3 interventions - of which ZuraPrep is the first listed.
NCT02831816 reports 1 study location spanning 1 distinct geographic area - top geographies include Montana.
Frequently Asked Questions
What is clinical trial NCT02831816 about?
NCT02831816 is a clinical study titled "Clinical Evaluation of Patient Preoperative Prep". The objective of the study is to demonstrate the antimicrobial efficacy of the ZP Preoperative Prep on skin flora of the abdomen and inguinal regions of human subjects.
What is the current status of trial NCT02831816?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 640 participants. The study started on 2016-08-03. Estimated completion is 2017-08-03.
What conditions does trial NCT02831816 study?
This clinical trial studies the following conditions: Surgical Skin Preparation.
What interventions are being tested in trial NCT02831816?
The interventions under investigation include: ZuraPrep (DRUG), ChloraPrep (DRUG), ZP Vehicle (DRUG).
Who is sponsoring clinical trial NCT02831816?
This trial is sponsored by Zurex Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02831816 being conducted?
This trial has 1 study location across Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Skin Preparation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.